Form 4: Veracyte SVP, General Counsel Annie McGuire Reports Sale of Common Stock

Annie McGuire, SVP, General Counsel of Veracyte, Inc., reports the sale of 1,142 shares of common stock on March 4, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 4, 2025, Annie McGuire, the SVP, General Counsel of Veracyte, Inc., sold 1,142 shares of common stock.
• The sale was executed at a weighted average price of $33.6922 per share.
• The transactions were made pursuant to a Rule 10b5-1 plan adopted on September 4, 2024.
• Following the transaction, McGuire directly owns 70,308 shares of Veracyte common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to an insider stock sale under a pre-arranged plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

This is a routine disclosure of an insider stock sale, which is common for executives at publicly traded companies. The sale was conducted under a pre-arranged trading plan, which is a common practice to avoid accusations of insider trading.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some shareholders, but the existence of a pre-arranged trading plan mitigates this concern.

Key Dates

Keywords

Form 4, Veracyte, VCYT, Annie McGuire, Rule 10b5-1, insider trading, stock sale, SVP, General Counsel